127 related articles for article (PubMed ID: 12480278)
1. Enhanced transdermal delivery of phenylalanyl-glycine by chemical modification with various fatty acids.
Yamamoto A; Setoh K; Murakami M; Shironoshita M; Kobayashi T; Fujimoto K; Okada N; Fujita T; Muranishi S
Int J Pharm; 2003 Jan; 250(1):119-28. PubMed ID: 12480278
[TBL] [Abstract][Full Text] [Related]
2. Enhanced permeability of phenylalanyl-glycine (Phe-Gly) across the intestinal membranes by chemical modification with various fatty acids.
Yamamoto A; Morishita Y; Sugishita S; Hayami T; Okada N; Fujita T; Muranishi S
Drug Metab Pharmacokinet; 2003; 18(1):23-32. PubMed ID: 15618716
[TBL] [Abstract][Full Text] [Related]
3. Improvement of transdermal delivery of tetragastrin by lipophilic modification with fatty acids.
Setoh K; Murakami M; Araki N; Fujita T; Yamamoto A; Muranishi S
J Pharm Pharmacol; 1995 Oct; 47(10):808-11. PubMed ID: 8583347
[TBL] [Abstract][Full Text] [Related]
4. Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids.
Yodoya E; Uemura K; Tenma T; Fujita T; Murakami M; Yamamoto A; Muranishi S
J Pharmacol Exp Ther; 1994 Dec; 271(3):1509-13. PubMed ID: 7996464
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of the small intestinal uptake of phenylalanylglycine via a H+/oligopeptide transport system by chemical modification with fatty acids.
Fujita T; Morishita Y; Ito H; Kuribayashi D; Yamamoto A; Muranishi S
Life Sci; 1997; 61(25):2455-65. PubMed ID: 9416764
[TBL] [Abstract][Full Text] [Related]
6. Development of novel lipophilic derivatives of DADLE (leucine enkephalin analogue): intestinal permeability characateristics of DADLE derivatives in rats.
Uchiyama T; Kotani A; Tatsumi H; Kishida T; Okamoto A; Okada N; Murakami M; Fujita T; Fujiwara Y; Kiso Y; Muranishi S; Yamamoto A
Pharm Res; 2000 Dec; 17(12):1461-7. PubMed ID: 11303954
[TBL] [Abstract][Full Text] [Related]
7. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
Yamamoto A
Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
[TBL] [Abstract][Full Text] [Related]
8. Exploring Alkyl Ester Salts of L-Amino Acid Derivatives of Ibuprofen: Physicochemical Characterization and Transdermal Potential.
Witkowski K; Nowak A; Duchnik W; Kucharski Ł; Struk Ł; Ossowicz-Rupniewska P
Molecules; 2023 Nov; 28(22):. PubMed ID: 38005244
[TBL] [Abstract][Full Text] [Related]
9. Relationships between mucosal hydrolysis and transport of two phenylalanine dipeptides.
Silk DB; Nicholson JA; Kim YS
Gut; 1976 Nov; 17(11):870-6. PubMed ID: 12068
[TBL] [Abstract][Full Text] [Related]
10. Absorption characteristics of chemically modified-insulin derivatives with various fatty acids in the small and large intestine.
Asada H; Douen T; Waki M; Adachi S; Fujita T; Yamamoto A; Muranishi S
J Pharm Sci; 1995 Jun; 84(6):682-7. PubMed ID: 7562404
[TBL] [Abstract][Full Text] [Related]
11. Skin permeation of acyl derivatives of stobadine.
Májeková M; Koprda V; Bohácik L; Bohov P; Hadgraft J; Bezáková Z; Májek P
Drug Deliv; 2006; 13(1):51-4. PubMed ID: 16401593
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe).
Larsen SW; Ankersen M; Larsen C
Eur J Pharm Sci; 2004 Aug; 22(5):399-408. PubMed ID: 15265509
[TBL] [Abstract][Full Text] [Related]
14. Transdermal delivery of contraceptives.
Friend DR
Crit Rev Ther Drug Carrier Syst; 1990; 7(2):149-86. PubMed ID: 2272099
[TBL] [Abstract][Full Text] [Related]
15. Dipeptide derivatives of primaquine as transmission-blocking antimalarials: effect of aliphatic side-chain acylation on the gametocytocidal activity and on the formation of carboxyprimaquine in rat liver homogenates.
Portela MJ; Moreira R; Valente E; Constantino L; Iley J; Pinto J; Rosa R; Cravo P; do Rosário VE
Pharm Res; 1999 Jun; 16(6):949-55. PubMed ID: 10397619
[TBL] [Abstract][Full Text] [Related]
16. Metabolic approaches to enhance transdermal drug delivery. 1. Effect of lipid synthesis inhibitors.
Tsai JC; Guy RH; Thornfeldt CR; Gao WN; Feingold KR; Elias PM
J Pharm Sci; 1996 Jun; 85(6):643-8. PubMed ID: 8773963
[TBL] [Abstract][Full Text] [Related]
17. Development of new lipophilic derivatives of tetragastrin: physicochemical characteristics and intestinal absorption of acyl-tetragastrin derivatives in rats.
Tenma T; Yodoya E; Tashima S; Fujita T; Murakami M; Yamamoto A; Muranishi S
Pharm Res; 1993 Oct; 10(10):1488-92. PubMed ID: 8272412
[TBL] [Abstract][Full Text] [Related]
18. Permeability characteristics of tetragastrins across intestinal membranes using the Caco-2 monolayer system: comparison between acylation and application of protease inhibitors.
Fujita T; Kawahara I; Quan Y; Hattori K; Takenaka K; Muranishi S; Yamamoto A
Pharm Res; 1998 Sep; 15(9):1387-92. PubMed ID: 9755890
[TBL] [Abstract][Full Text] [Related]
19. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
Kumar D; Ali J; Baboota S
Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
[TBL] [Abstract][Full Text] [Related]
20. Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel.
Panchagnula R; Desu H; Jain A; Khandavilli S
J Pharm Sci; 2004 Sep; 93(9):2177-83. PubMed ID: 15295779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
